ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Sonoma Pharmaceuticals, Inc. ?
1
With a growth in Net Sales of 15.2%, the company declared Outstanding results in Jun 26
- The company has declared positive results for the last 4 consecutive quarters
- ROCE(HY) Highest at -42.52%
- RAW MATERIAL COST(Y) Fallen by -10.63% (YoY)
- INVENTORY TURNOVER RATIO(HY) Highest at 3.53 times
Real-Time Research ReportHow much should you buy?
- Overall Portfolio exposure to Sonoma Pharmaceuticals, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Sonoma Pharmaceuticals, Inc. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Sonoma Pharmaceuticals, Inc.
-69.06%
-0.93
74.14%
S&P 500
15.76%
1.22
13.15%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-3.39%
EBIT Growth (5y)
3.42%
EBIT to Interest (avg)
-4.46
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.16
Sales to Capital Employed (avg)
2.91
Tax Ratio
18.92%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
9.36%
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.07
EV to EBIT
-0.46
EV to EBITDA
-0.48
EV to Capital Employed
1.25
EV to Sales
0.07
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-271.98%
ROE (Latest)
-98.19%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend23What is working for the Company
ROCE(HY)
Highest at -42.52%
RAW MATERIAL COST(Y)
Fallen by -10.63% (YoY
INVENTORY TURNOVER RATIO(HY)
Highest at 3.53 times
DEBTORS TURNOVER RATIO(HY)
Highest at 7.58 times
NET SALES(Q)
Highest at USD 6.41 MM
OPERATING PROFIT(Q)
Highest at USD -0.01 MM
OPERATING PROFIT MARGIN(Q)
Highest at -0.12 %
PRE-TAX PROFIT(Q)
Highest at USD -0.33 MM
NET PROFIT(Q)
Highest at USD -0.33 MM
EPS(Q)
Highest at USD -0.09
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Here's what is working for Sonoma Pharmaceuticals, Inc.
Net Sales
Highest at USD 6.41 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (USD MM)
Net Sales
At USD 6.41 MM has Grown at 31.21%
over average net sales of the previous four periods of USD 4.88 MMMOJO Watch
Near term sales trend is positive
Net Sales (USD MM)
Operating Profit
Highest at USD -0.01 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (USD MM)
Operating Profit Margin
Highest at -0.12 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Pre-Tax Profit
Highest at USD -0.33 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (USD MM)
Pre-Tax Profit
At USD -0.33 MM has Grown at 61.39%
over average net sales of the previous four periods of USD -0.85 MMMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (USD MM)
Net Profit
Highest at USD -0.33 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (USD MM)
Net Profit
At USD -0.33 MM has Grown at 58.43%
over average net sales of the previous four periods of USD -0.79 MMMOJO Watch
Near term Net Profit trend is positive
Net Profit (USD MM)
EPS
Highest at USD -0.09
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (USD)
Inventory Turnover Ratio
Highest at 3.53 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Debtors Turnover Ratio
Highest at 7.58 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Raw Material Cost
Fallen by -10.63% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Footer loading
